Address
Email address
Phone number
https://sydameapteek.eeKõik ravimid Südameapteegi e-apteegistSüdameapteegi e-apteek: telli mugavalt ravimid, toidulisandid, vitamiinid ja apteegikosmeetika pakiautomaati, apteeki või koju. Tarne alates 0 eurot.
Name
Pharma Holding OÜ
Registry code
12009590
VAT number
EE101511045
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
21.10.2010 (14)
Financial year
01.01-31.12
Capital
4 557.00 €
Activity
77401 - Leasing of intellectual property and similar products, except copyrighted works
10 135 708 €
523 395 €
5%
-
7 052 602 €
35
Submitted
No tax arrears
7%
4%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Pharma Holding OÜ 12009590 | 17% - 797.00 EUR | - | - | |
| SA Holding OÜ 16508462 | 83% - 3 760.00 EUR | - | - | |
| Omanikukonto: RISTO LAUR 20.10.1979 (45) | - | Board member | Indirect ownership | |
| Eveli Adrikorn 31.07.1984 (40) | - | Board member | - | |
| Tarmo Laanetu 12.12.1974 (49) | - | - | - | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Pharma Holding OÜ 12009590 | 17% - 797.00 EUR | - | - |
| 2019 30.06.2020 | 2020 30.06.2021 | 2021 30.06.2022 | 2022 30.06.2023 | 2023 30.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 61 750 135 € | 23 358 636 € | 9 298 745 € | 10 444 884 € | 10 135 708 € |
| Net profit (loss) for the period | - | - | - | - | 523 395 € |
| Profit Margin | - | - | - | - | 5% |
| Current Assets | - | - | - | - | 2 476 776 € |
| Fixed Assets | - | - | - | - | 10 599 513 € |
| Total Assets | 23 670 242 € | 17 922 662 € | 1 636 356 € | 13 607 307 € | 13 076 289 € |
| Current Liabilities | - | - | - | - | 4 213 687 € |
| Non Current Liabilities | - | - | - | - | 1 810 000 € |
| Total Liabilities | - | - | - | - | 6 023 687 € |
| Share Capital | - | - | - | - | - |
| Equity | - | - | - | - | 7 052 602 € |
| Employees | 344 | 31 | 34 | 37 | 35 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 4 294 609.5 € | 102 302.47 € | 202 823.55 € | 29 |
| 2023 Q4 | 5 250 238.42 € | 355 366.05 € | 211 878.91 € | 31 |
| 2023 Q3 | 4 806 491.07 € | 351 506.02 € | 211 478.69 € | 31 |
| 2023 Q2 | 5 188 444.37 € | 370 488.75 € | 241 593.26 € | 31 |
| 2023 Q1 | 4 798 388.56 € | 345 998.82 € | 254 223.56 € | 33 |
| 2022 Q4 | 5 215 585.94 € | 337 269.65 € | 189 200.77 € | 34 |
| 2022 Q3 | 4 637 659.52 € | 301 027.05 € | 178 068.32 € | 30 |
| 2022 Q2 | 4 647 774.54 € | 340 113.46 € | 241 170.9 € | 30 |
| 2022 Q1 | 4 606 574.92 € | 271 789.23 € | 177 021.21 € | 32 |
| 2021 Q4 | 4 691 797.33 € | 231 999.32 € | 173 364.15 € | 30 |
| 2021 Q3 | 3 988 040.05 € | 234 873.67 € | 165 823.82 € | 31 |
| 2021 Q2 | 4 051 383.47 € | 316 815.44 € | 202 690.14 € | 29 |
| 2021 Q1 | 3 908 751.78 € | 238 826.96 € | 158 684.34 € | 31 |
| 2020 Q4 | 3 527 437.51 € | 189 416.85 € | 144 722.11 € | 31 |
| 2020 Q3 | 2 215 009.28 € | 145 885.23 € | 151 926.27 € | 32 |
| 2020 Q2 | 1 818 258.92 € | 177 966.27 € | 187 436.22 € | 29 |
| 2020 Q1 | 2 124 440.84 € | 164 747.95 € | 165 111.45 € | 30 |
